Your browser doesn't support javascript.
loading
Mesothelin-specific CAR-T cell therapy that incorporates an HLA-gated safety mechanism selectively kills tumor cells.
Tokatlian, Talar; Asuelime, Grace E; Mock, Jee-Young; DiAndreth, Breanna; Sharma, Shruti; Toledo Warshaviak, Dora; Daris, Mark E; Bolanos, Kristian; Luna, Breanna L; Naradikian, Martin S; Deshmukh, Kiran; Hamburger, Agnes E; Kamb, Alexander.
  • Tokatlian T; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Asuelime GE; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Mock JY; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • DiAndreth B; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Sharma S; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Toledo Warshaviak D; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Daris ME; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Bolanos K; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Luna BL; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Naradikian MS; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Deshmukh K; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Hamburger AE; A2 Biotherapeutics Inc, Agoura Hills, California, USA.
  • Kamb A; A2 Biotherapeutics Inc, Agoura Hills, California, USA akamb@a2biotherapeutics.com.
J Immunother Cancer ; 10(1)2022 01.
Article en En | MEDLINE | ID: mdl-35091455

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno HLA-A2 / Inmunoterapia Adoptiva / Receptores Quiméricos de Antígenos / Mesotelina / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Antígeno HLA-A2 / Inmunoterapia Adoptiva / Receptores Quiméricos de Antígenos / Mesotelina / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Año: 2022 Tipo del documento: Article